pyridoxine has been researched along with Arteriosclerosis, Coronary in 7 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Homocysteine is increasingly recognized as a risk factor for coronary artery disease." | 4.79 | Homocysteine and coronary atherosclerosis. ( Jacobsen, DW; Mayer, EL; Robinson, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LUKOMSKII, PE | 1 |
| Jonasson, T | 1 |
| Ohlin, AK | 1 |
| Gottsäter, A | 1 |
| Hultberg, B | 1 |
| Ohlin, H | 1 |
| Mayer, EL | 1 |
| Jacobsen, DW | 1 |
| Robinson, K | 1 |
| Siri, PW | 1 |
| Verhoef, P | 1 |
| Kok, FJ | 1 |
| Bostom, AG | 1 |
| Garber, C | 1 |
| Vermeulen, EG | 1 |
| Stehouwer, CD | 1 |
| Twisk, JW | 1 |
| van den Berg, M | 1 |
| de Jong, SC | 1 |
| Mackaay, AJ | 1 |
| van Campen, CM | 1 |
| Visser, FC | 1 |
| Jakobs, CA | 1 |
| Bulterjis, EJ | 1 |
| Rauwerda, JA | 1 |
| Olszewski, AJ | 1 |
| Szostak, WB | 1 |
| Bialkowska, M | 1 |
| Rudnicki, S | 1 |
| McCully, KS | 1 |
1 review available for pyridoxine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Homocysteine and coronary atherosclerosis.
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Homocystinuria; Humans; Pyridoxine; Risk Factors; | 1996 |
2 trials available for pyridoxine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocystei | 2005 |
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
Topics: Blood Pressure; Coronary Artery Disease; Family; Female; Folic Acid; Hematinics; Humans; Hyperhomocy | 2000 |
4 other studies available for pyridoxine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Use of methionine, pyridoxine and unsaturated fatty acids in coronary atherosclerosis].
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Fatty Acids; | 1959 |
Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.
Topics: Adult; Aged; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; P | 1998 |
Endpoints for homocysteine-lowering trials.
Topics: Adult; Aged; Child; Coronary Artery Disease; Folic Acid; Hematinics; Humans; Hyperhomocysteinemia; P | 2000 |
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis.
Topics: Adult; Anticoagulants; Choline; Coronary Artery Disease; Coronary Disease; Drug Therapy, Combination | 1989 |